Positron emission tomography

An overview

A. Shukla, Utham Kumar

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

The rate of glucose utilization in tumor cells is significantly enhanced as compared to normal cells and this biochemical characteristic is utilized in PET imaging using FDG as a major workhorse. The PET systems as well as cyclotrons producing positron emitting radiopharmaceuticals have undergone continuous technological refinements. While PET (CT) systems enable fusion images as well as precise attenuation correction, the self-shielded cyclotrons developed provide dedicated systems for in-house production of a large number of PET radiopharmaceuticals. The application of PET images in oncology includes those of pulmonary, colorectal, breast, lymphoma, head & neck, bone, ovarian and GI cancers. The PET has been recognized as promising diagnostic tool to predict biological and physiological changes at the molecular level and hence offer a potential area for future applications including Stem Cell research.

Original languageEnglish
Pages (from-to)13-21
Number of pages9
JournalJournal of Medical Physics
Volume31
Issue number1
Publication statusPublished - 2006

Fingerprint

Cyclotrons
Radiopharmaceuticals
Positron-Emission Tomography
Stem Cell Research
Ovarian Neoplasms
Lymphoma
Breast
Neck
Head
Electrons
Bone and Bones
Glucose
Lung
Neoplasms

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Shukla, A. ; Kumar, Utham. / Positron emission tomography : An overview. In: Journal of Medical Physics. 2006 ; Vol. 31, No. 1. pp. 13-21.
@article{941da2ad7a1c4a67ab8ad1f2cdba0d42,
title = "Positron emission tomography: An overview",
abstract = "The rate of glucose utilization in tumor cells is significantly enhanced as compared to normal cells and this biochemical characteristic is utilized in PET imaging using FDG as a major workhorse. The PET systems as well as cyclotrons producing positron emitting radiopharmaceuticals have undergone continuous technological refinements. While PET (CT) systems enable fusion images as well as precise attenuation correction, the self-shielded cyclotrons developed provide dedicated systems for in-house production of a large number of PET radiopharmaceuticals. The application of PET images in oncology includes those of pulmonary, colorectal, breast, lymphoma, head & neck, bone, ovarian and GI cancers. The PET has been recognized as promising diagnostic tool to predict biological and physiological changes at the molecular level and hence offer a potential area for future applications including Stem Cell research.",
author = "A. Shukla and Utham Kumar",
year = "2006",
language = "English",
volume = "31",
pages = "13--21",
journal = "Journal of Medical Physics",
issn = "0971-6203",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

Positron emission tomography : An overview. / Shukla, A.; Kumar, Utham.

In: Journal of Medical Physics, Vol. 31, No. 1, 2006, p. 13-21.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Positron emission tomography

T2 - An overview

AU - Shukla, A.

AU - Kumar, Utham

PY - 2006

Y1 - 2006

N2 - The rate of glucose utilization in tumor cells is significantly enhanced as compared to normal cells and this biochemical characteristic is utilized in PET imaging using FDG as a major workhorse. The PET systems as well as cyclotrons producing positron emitting radiopharmaceuticals have undergone continuous technological refinements. While PET (CT) systems enable fusion images as well as precise attenuation correction, the self-shielded cyclotrons developed provide dedicated systems for in-house production of a large number of PET radiopharmaceuticals. The application of PET images in oncology includes those of pulmonary, colorectal, breast, lymphoma, head & neck, bone, ovarian and GI cancers. The PET has been recognized as promising diagnostic tool to predict biological and physiological changes at the molecular level and hence offer a potential area for future applications including Stem Cell research.

AB - The rate of glucose utilization in tumor cells is significantly enhanced as compared to normal cells and this biochemical characteristic is utilized in PET imaging using FDG as a major workhorse. The PET systems as well as cyclotrons producing positron emitting radiopharmaceuticals have undergone continuous technological refinements. While PET (CT) systems enable fusion images as well as precise attenuation correction, the self-shielded cyclotrons developed provide dedicated systems for in-house production of a large number of PET radiopharmaceuticals. The application of PET images in oncology includes those of pulmonary, colorectal, breast, lymphoma, head & neck, bone, ovarian and GI cancers. The PET has been recognized as promising diagnostic tool to predict biological and physiological changes at the molecular level and hence offer a potential area for future applications including Stem Cell research.

UR - http://www.scopus.com/inward/record.url?scp=33747646920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747646920&partnerID=8YFLogxK

M3 - Review article

VL - 31

SP - 13

EP - 21

JO - Journal of Medical Physics

JF - Journal of Medical Physics

SN - 0971-6203

IS - 1

ER -